Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
COVID and Vaccine-related Cerebral Venous Thrombosis
View through CrossRef
The coronavirus disease-2019 (COVID-19) pandemic has been a major threat to global health. It primarily affects the respiratory system but multiple organs, including the nervous system, can be affected. Cerebral venous thrombosis (CVT) has been reported among COVID-19 patients as well as among recipients of COVID vaccines. CVT often remains a diagnostic challenge due to highly variable clinical presentation. We underwent a thorough narrative review of the published literature from January 2020 to April 2023 in the Medline (PubMed) database. Our search led to 66 studies in total, 30 related to COVID-CVT and 36 related to COVID vaccine-CVT. We further looked for differences between these COVID-CVT and COVID vaccine-associated-CVT and their possible pathophysiology, treatment options, and prognosis. A few things that were highlighted during our search: COVID increases CVT risk and can happen without respiratory manifestations. COVID-CVT is more common in middle-aged men and has a higher morality compared to traditional non-COVID-CVT. COVID vaccines also increase the risk of CVT but less than the COVID infection. COVID vaccine-CVT is further divided into two groups having either normal platelets or low platelets. The latter group is better reported and has a higher inpatient mortality and disability at discharge but these patients usually recover well in the follow-up period. Non-heparin anticoagulation, immunomodulation, and surgery are the main treatment options.
Title: COVID and Vaccine-related Cerebral Venous Thrombosis
Description:
The coronavirus disease-2019 (COVID-19) pandemic has been a major threat to global health.
It primarily affects the respiratory system but multiple organs, including the nervous system, can be affected.
Cerebral venous thrombosis (CVT) has been reported among COVID-19 patients as well as among recipients of COVID vaccines.
CVT often remains a diagnostic challenge due to highly variable clinical presentation.
We underwent a thorough narrative review of the published literature from January 2020 to April 2023 in the Medline (PubMed) database.
Our search led to 66 studies in total, 30 related to COVID-CVT and 36 related to COVID vaccine-CVT.
We further looked for differences between these COVID-CVT and COVID vaccine-associated-CVT and their possible pathophysiology, treatment options, and prognosis.
A few things that were highlighted during our search: COVID increases CVT risk and can happen without respiratory manifestations.
COVID-CVT is more common in middle-aged men and has a higher morality compared to traditional non-COVID-CVT.
COVID vaccines also increase the risk of CVT but less than the COVID infection.
COVID vaccine-CVT is further divided into two groups having either normal platelets or low platelets.
The latter group is better reported and has a higher inpatient mortality and disability at discharge but these patients usually recover well in the follow-up period.
Non-heparin anticoagulation, immunomodulation, and surgery are the main treatment options.
Related Results
Burden of the Beast
Burden of the Beast
Introduction
Throughout the COVID-19 pandemic, and its fluctuating waves of infections and the emergence of new variants, Indigenous populations in Australia and worldwide have re...
The Prevalence of JAK2 Mutation in High-Altitude Patients with Unprovoked Thrombosis and Thrombosis at Unusual Sites
The Prevalence of JAK2 Mutation in High-Altitude Patients with Unprovoked Thrombosis and Thrombosis at Unusual Sites
Introduction
Thrombosis, both arterial and venous, is a major source of morbidity and mortality in patients with myeloproliferative neoplasms (MPNs). Thrombosis can ...
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
Venous Thromboembolism in Denmark: Seasonality in Occurrence and Mortality
Background Many cardiovascular conditions exhibit seasonality in occurrence and mortality, but little is known about the seasonality of venous thromboembolism.
Methods ...
Aspiration thrombectomy for the management of acute deep venous thrombosis in the setting of venous thoracic outlet syndrome
Aspiration thrombectomy for the management of acute deep venous thrombosis in the setting of venous thoracic outlet syndrome
Objectives
Venous thoracic outlet syndrome, known by the eponym Paget–Schroetter syndrome, is seen in healthy, young individuals with “effort-induced thrombosis...
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Determinants of Cerebrovascular Reserve in Patients with Significant Carotid Stenosis
Abstract
Introduction
In patients with 70% to 99% diameter carotid artery stenosis cerebral blood flow reserve may be protectiv...
FEATURES OF RHEOENCEPHALOGRAPHY INDICATORS IN MILITARY PERSONNEL BEFORE AND AFTER TREATMENT WHO SUFFERED ACOUSTIC BAROTRAUMA IN REAL COMBAT CONDITIONS
FEATURES OF RHEOENCEPHALOGRAPHY INDICATORS IN MILITARY PERSONNEL BEFORE AND AFTER TREATMENT WHO SUFFERED ACOUSTIC BAROTRAUMA IN REAL COMBAT CONDITIONS
Relevance: As a result of military actions in Ukraine, the number of affected individuals in need of medical care is increasing, especially after explosive trauma. The use of objec...
COVID-19 Vaccine Hesitancy, Adverse Events Following Immunization, and Associated Factors among Ethiopian General Population During Early Phase of COVID-19 Vaccination Program
COVID-19 Vaccine Hesitancy, Adverse Events Following Immunization, and Associated Factors among Ethiopian General Population During Early Phase of COVID-19 Vaccination Program
Abstract
Aim: This study aimed at assessing COVID-19 vaccine hesitancy, adverse events after immunization, and associated factors among the general population during the ea...